Sleep Quality and Human Amlyoid-Beta Kinetics
睡眠质量和人类β淀粉样蛋白动力学
基本信息
- 批准号:9927556
- 负责人:
- 金额:$ 15.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:Abeta synthesisAddressAdultAffectAgingAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmericanAmino AcidsAmyloidAmyloid beta-42Amyloid beta-ProteinBedsBrainCathetersCell DeathCerebrospinal FluidClinical Trials DesignCognitiveControl GroupsDataDementiaDevelopmentDevelopment PlansDiseaseDrug ControlsElderlyEnvironmentEquipmentFoundationsFrequenciesFundingGeriatricsGoalsHourHumanImpaired cognitionIndividualInfusion proceduresIntercellular FluidInternationalKineticsLaboratoriesMass Spectrum AnalysisMeasuresMediatingMentorsMentorshipMetabolic Clearance RateMonitorMusNerve DegenerationNeuraxisNeurodegenerative DisordersNeurofibrillary TanglesNeurologyParticipantPathogenesisPatternPharmaceutical PreparationsPharmacologyPhasePhysiciansPlacebosPolysomnographyPrevalencePreventionPrevention trialProductionProteinsPublic HealthResearchResearch PersonnelResearch Project GrantsRoleSamplingScientistSenile PlaquesSleepSleep ArchitectureSleep DeprivationSleep DisordersSleep disturbancesStable Isotope LabelingTestingTimeTrainingTranslatingTranslational ResearchUniversitiesWakefulnessWashingtonWorkabeta depositionactigraphyagedaging populationbasecareercareer developmentdata managementexperienceextracellularhypocretinimprovedin vivoinnovationinterestmedical schoolsmeetingsnovelnovel therapeuticspreventprofessorprogramsreceptorresponseresponsible research conductsleep qualitysleep regulationsquare foottargeted treatmenttau aggregationtenure tracktreatment strategy
项目摘要
Project Summary:
Dr. Brendan Lucey, MD is a highly-motivated physician-scientist with a strong interest in sleep, aging, and
neurodegenerative disorders such as Alzheimer's disease. He was recently promoted to Assistant Professor
of Neurology (tenure track) at Washington University and is now seeking support for further mentorship as he
focuses on a novel treatment strategy for Alzheimer's disease. Building on pioneering research at Washington
University, Dr. Lucey is now studying how different sleep conditions (e.g. sleep deprivation, sleep induction
with medication, normal sleep control) affect the central nervous system (CNS) production, clearance, and
concentration of amyloid-β (Aβ). He has found that sleep deprivation significantly increases CNS Aβ and
preliminary findings suggest that a similar increase in CNS Aβ occurs in individuals with poor sleep efficiency
(i.e. poor sleep quality). Using a stable isotope labeled amino acid to determine in vivo Aβ production and
clearance rates, Dr. Lucey will test: 1) if CNS Aβ production, clearance, and concentration are increased in
individuals with poor sleep efficiency compared to those with good sleep efficiency; 2) if treating individuals
with poor sleep efficiency treated with a sleep-inducing drug (suvorexant, a dual orexin receptor antagonist) will
decrease CNS Aβ production, clearance, and concentration compared to controls. His short-term goals are to
address fundamental and impactful questions of Alzheimer's disease and sleep by establishing an academic
career, expanding his translational research group with independent funding (R01), and gain world-leading
expertise in the understanding and treatment of sleep problems in older adults without and with
neurodegenerative disorders such as Alzheimer's disease. Dr. Lucey's long-term goal is to develop an exciting
research program investigating the interrelationships between sleep, aging, and Alzheimer's disease.
Understanding these relationships could drive the development of new treatments to prevent or delay
Alzheimer's disease. To accomplish these goals, he has enlisted an outstanding experienced investigator in
aging research as mentor, Dr. Randall Bateman, as well as a career development advisory panel of
international leaders in the fields of sleep research, geriatrics, aging, and Alzheimer's disease (Drs. Paul Shaw,
David Holtzman, and David Carr). His career development plan includes: 1) frequent meetings with his
mentor and advisory panel; 2) attendance and presentation at neurodegeneration, aging, and sleep focused
seminars; 3) relevant coursework in clinical trial design, data management, aging, and mass spectrometry; 4)
on-going training in the responsible conduct of research. Washington University School of Medicine has an
outstanding track record of mentorship, in particular with K awardees, and has multiple labs focused on aging
and neurodegenerative disorders. This will provide a rich and supportive scientific environment for mentorship
in aging research. Dr. Lucey has ample (~400 square feet) laboratory space and equipment to accomplish this
research project.
项目概要:
博士Brendan Lucey医学博士是一位积极进取的医生科学家,对睡眠、衰老和
神经退行性疾病,如阿尔茨海默病。他最近被提升为助理教授
他是华盛顿大学神经病学教授(终身教职),现在正在寻求进一步指导的支持,
专注于阿尔茨海默病的新治疗策略。以华盛顿的开创性研究为基础
Lucey博士现在正在研究不同的睡眠条件(例如睡眠剥夺,睡眠诱导)
与药物,正常睡眠控制)影响中枢神经系统(CNS)的生产,清除,
淀粉样蛋白-β(Aβ)的浓度。他发现睡眠不足会显着增加中枢神经系统Aβ,
初步研究结果表明,睡眠效率差的个体也会出现类似的CNS Aβ增加
(i.e.睡眠质量差)。使用稳定同位素标记的氨基酸来测定体内Aβ的产生,
清除率,Lucey博士将测试:1)如果CNS Aβ的产生、清除和浓度增加,
与睡眠效率良好的人相比,睡眠效率差的人; 2)如果治疗个体
用睡眠诱导药物(suvorexant,一种双重食欲素受体拮抗剂)治疗睡眠效率差的患者,
与对照组相比,CNS Aβ产生、清除和浓度降低。他的短期目标是
通过建立学术机构来解决阿尔茨海默病和睡眠的基本且有影响力的问题
职业生涯,扩大他的翻译研究小组与独立的资金(R 01),并获得世界领先的
了解和治疗老年人睡眠问题的专业知识,
神经退行性疾病,如阿尔茨海默病。Lucey博士的长期目标是开发一种令人兴奋的
一项研究计划,调查睡眠、衰老和阿尔茨海默病之间的相互关系。
了解这些关系可以推动新疗法的发展,以防止或延迟
老年痴呆症为了实现这些目标,他招募了一位杰出的经验丰富的调查员,
作为导师,兰德尔贝特曼博士,以及一个职业发展咨询小组,
睡眠研究、老年医学、衰老和阿尔茨海默病领域的国际领导者(Drs. PaulShaw,
大卫霍尔茨曼和大卫卡尔)。他的职业发展计划包括:1)经常与他的
导师和咨询小组; 2)出席和介绍神经变性,老化,和睡眠集中
研讨会; 3)临床试验设计,数据管理,老化和质谱的相关课程; 4)
持续进行负责任的研究培训。华盛顿大学医学院有一个
杰出的指导记录,特别是与K获奖者,并有多个实验室专注于老龄化
和神经退行性疾病。这将为导师制提供丰富和支持性的科学环境
在衰老研究中。Lucey博士有充足的(约400平方英尺)实验室空间和设备来完成这项工作
研究项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brendan Patrick Lucey其他文献
Brendan Patrick Lucey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brendan Patrick Lucey', 18)}}的其他基金
Effect of Suvorexant on Alzheimer's Disease Biomarkers
Suvorexant 对阿尔茨海默病生物标志物的影响
- 批准号:
10584093 - 财政年份:2023
- 资助金额:
$ 15.57万 - 项目类别:
Characterization of Orexin/Hypocretin Kinetics in Alzheimer's Disease
阿尔茨海默病中食欲素/下丘脑分泌素动力学的表征
- 批准号:
10491248 - 财政年份:2021
- 资助金额:
$ 15.57万 - 项目类别:
Characterization of Orexin/Hypocretin Kinetics in Alzheimer's Disease
阿尔茨海默病中食欲素/下丘脑分泌素动力学的表征
- 批准号:
10300328 - 财政年份:2021
- 资助金额:
$ 15.57万 - 项目类别:
SLEEP QUALITY AND HUMAN AMLYOID-BETA KINETICS
睡眠质量和人类淀粉样蛋白-β 动力学
- 批准号:
9934836 - 财政年份:2016
- 资助金额:
$ 15.57万 - 项目类别:
SLEEP: A POTENTIAL NOVEL MODULATOR OF ALZHEIMER'S DISEASE PATHOLOGY
睡眠:阿尔茨海默病病理学的潜在新型调节剂
- 批准号:
8755446 - 财政年份:2014
- 资助金额:
$ 15.57万 - 项目类别:
Sleep and Orexin: Potential Markers of Progression from Preclinical to Mildly Symptomatic Alzheimer's Disease
睡眠和食欲素:从临床前到轻度症状阿尔茨海默病进展的潜在标志
- 批准号:
10622500 - 财政年份:1997
- 资助金额:
$ 15.57万 - 项目类别:
Sleep and Orexin: Potential Markers of Progression from Preclinical to Mildly Symptomatic Alzheimer's Disease
睡眠和食欲素:从临床前到轻度症状阿尔茨海默病进展的潜在标志
- 批准号:
10396450 - 财政年份:1997
- 资助金额:
$ 15.57万 - 项目类别:
Sleep and Orexin: Potential Markers of Progression from Preclinical to Mildly Symptomatic Alzheimer's Disease
睡眠和食欲素:从临床前到轻度症状阿尔茨海默病进展的潜在标志
- 批准号:
9914186 - 财政年份:
- 资助金额:
$ 15.57万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 15.57万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 15.57万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 15.57万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 15.57万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 15.57万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 15.57万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15.57万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 15.57万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15.57万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 15.57万 - 项目类别:
Research Grant














{{item.name}}会员




